GlassScriptPhysician profile
Scott R Schaffer
NPI 1013940717
$2,450.21
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $312 · 2021: $348 · 2022: $441 · 2023: $493 · 2024: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $428.50 | 2019-2023 | |
| Glaxosmithkline, LLC. | $369.94 | 2021-2024 | Nucala |
| Genzyme Corporation | $316.97 | 2019-2024 | |
| Alk-Abello, INC | $230.17 | 2019-2023 | Odactra, Ragwitek, Grastek |
| Kaleo, INC. | $174.56 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $165.21 | 2019-2024 | Dupixent |
| Abbott Laboratories | $111.69 | 2022 | |
| Jazz Pharmaceuticals INC. | $102.65 | 2019-2021 | |
| Cochlear Americas | $98.60 | 2019-2024 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Acclarent, INC | $65.59 | 2019-2023 | Relieva Spinplus, Acclarent Aera |
| Smith+Nephew, INC. | $45.11 | 2021 | |
| Intersect Ent, INC. | $42.25 | 2019-2022 | |
| Stryker Corporation | $37.47 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $34.35 | 2023-2024 | Lumryz |
| Karl Storz Endoscopy-America | $32.35 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Quidel Corporation | $31.76 | 2019 | |
| Merck Sharp & Dohme LLC | $29.22 | 2021-2023 | |
| Aerin Medical INC. | $28.36 | 2020-2022 | |
| Resmed Corp | $18.05 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.57 | 2019 | |
| Olympus America INC. | $16.28 | 2019 | |
| Greer Laboratories, INC. | $15.26 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.22 | 2021 | |
| Phadia US INC. | $12.35 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.